3 ms·
It's so old, the patent is nearing expiration.
by stavros 11mo ago
It's so old, the patent is nearing expiration.
- wombatpm 11mo agoThat’s usually the case for new classes of drugs.
- scheme271 11mo agoThe first generation of GLP-1 agonists are out of patent protection. Teva is producing a generic liraglutide (aka Victoza / Saxenda). Ozempic (semiglutide) and Mounjaro (tirzepatide) have protection until after 2031 in the US, I think it's less in other countries.